Ranexa and Ebrantil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ranexa (ranolazine) and Ebrantil (urapidil). Common drug interactions include dizziness among males.
The phase IV clinical study analyzes what interactions people have when they take Ranexa and Ebrantil. It is created by eHealthMe based on reports of 9 people who take the same drugs from the FDA, and is updated regularly.
What is Ranexa?
Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.
What is Ebrantil?
Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.
9 people who take Ranexa and Ebrantil together, and have interactions are studied.

What are the common drug interactions of Ranexa and Ebrantil, by gender? *:
female:
n/a
male:
- Dizziness
- General physical health deterioration (weak health status)
- Faeces discoloured
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Respiration (transport of oxygen from the outside air to the cells within tissues)
- Gait disturbance
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Psoriasis (immune-mediated disease that affects the skin)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
What are the common drug interactions of Ranexa and Ebrantil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Cardiac arrest
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Faeces discoloured
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Gait disturbance
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Psoriasis (immune-mediated disease that affects the skin)
60+:
- Dizziness
- General physical health deterioration (weak health status)
- Hypotension (abnormally low blood pressure)
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Drug ineffective
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Respiration (transport of oxygen from the outside air to the cells within tissues)
* Approximation only. Some reports may have incomplete information.
Do you take Ranexa and Ebrantil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ranexa and Ebrantil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ranexa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ebrantil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ranexa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ebrantil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ranolazine and urapidil (the active ingredients of Ranexa and Ebrantil, respectively), and Ranexa and Ebrantil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Burkitt Lymphoma and Haematochezia - 10 seconds ago
- Methotrexate Sodium and Sepsis for Men aged 60+ - 11 seconds ago
- Advil and Pain Relief for Women aged 20-29 - 14 seconds ago
- Advil and Hypnosis And Pain for Women aged 20-29 - 14 seconds ago
- Advil and Alternative Medicine - Pain Relief for Women aged 20-29 - 14 seconds ago
- Advil and Pain for Women aged 20-29 - 15 seconds ago
- Diovan and Ejection Fraction Decreased for Men aged 60+ - 16 seconds ago
- Could Niacin cause Hair Loss? - 21 seconds ago
- Escitalopram vs. Olanzapine, side effect and effectiveness comparison - 22 seconds ago
- Dyspnea Exacerbated and drugs of ingredients of atropine sulfate; diphenoxylate hydrochloride - 26 seconds ago